Your browser doesn't support javascript.
loading
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
Ge, Fangfang; Wang, Yulu; Sharma, Amit; Yang, Yu; Liu, Hongde; Essler, Markus; Jaehde, Ulrich; Schmidt-Wolf, Ingo G H.
Afiliación
  • Ge F; Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital of Bonn, 53127 Bonn, Germany.
  • Wang Y; Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital of Bonn, 53127 Bonn, Germany.
  • Sharma A; Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital of Bonn, 53127 Bonn, Germany.
  • Yang Y; Department of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.
  • Liu H; State Key Laboratory of Bioelectronics, School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, China.
  • Essler M; State Key Laboratory of Bioelectronics, School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, China.
  • Jaehde U; Department of Nuclear Medicine, University Hospital Bonn, 53127 Bonn, Germany.
  • Schmidt-Wolf IGH; Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, 53121 Bonn, Germany.
Int J Mol Sci ; 24(15)2023 Aug 05.
Article en En | MEDLINE | ID: mdl-37569852

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Células Asesinas Inducidas por Citocinas / Antineoplásicos Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Células Asesinas Inducidas por Citocinas / Antineoplásicos Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Alemania